相关实验视频
Updated: Jun 16, 2026
08:26
Author Spotlight: Advancing Personalized Medicine in Ovarian Cancer
Published on: February 23, 2024
1.8K
诊断相关的群体为妇科瘤诊所提供资金:系统性审查
Alexandra Titopoulou1, Eleftherios Vavoulidis2, Chrysoula Margioula-Siarkou2
1Hippokration General Hospital of Thessaloniki, 54642 Thessaloniki, Greece.
Healthcare (Basel, Switzerland)
|February 25, 2025
概括
基于诊断相关群体 (DRG) 的融资在妇科瘤学补偿方面存在挑战. 基于病例和基于价值的结合支付模式可能为整体患者护理提供可持续的解决方案.
科学领域:
- 卫生经济学 卫生经济学
- 在瘤学瘤学.
- 医疗保健管理的管理
背景情况:
- 基于诊断相关的群体 (DRG) 融资是高收入国家的主要偿还模式.
- 近40年来,基于DRG的资金对妇科瘤学资金的影响仍然不清楚.
- 在妇科瘤学中对DRG的实施存在有限的数据.
研究的目的:
- 在妇科瘤学中系统审查基于DRG的系统.
- 评估全球DRG实施的优势和挑战.
- 探索替代性和补充性报销计划.
主要方法:
- 使用谷歌学者和PubMed进行了全面的文献审查.
- 确定了173篇潜在文章,其中15篇正在进行深入分析.
- 对所有已识别的物品进行了资格和相关性评估.
主要成果:
- 基于DRG的融资,虽然通常是有益的,但在妇科瘤学中面临着重大挑战.
- 目前的报销结构可能无法充分解决妇科癌症护理的复杂性.
- 需要进一步的研究来优化金融模型的这个专业.
结论:
- 提出了一种结合基于案例和基于价值的支付模式的创新方法.
- 这种混合模式旨在将医疗保健服务扩展到急性治疗阶段之外.
- 目标是实现在妇科瘤学中实现经济可持续,整体的医疗保健服务.
相关概念视频
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:56Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...